Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Working Capital/Sales

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Working Capital/Sales(x) 1.742.292.642.632.57

What is the latest Working Capital/Sales ratio of MEDICAMEN BIOTECH ?

The latest Working Capital/Sales ratio of MEDICAMEN BIOTECH is 1.74 based on Mar2023 Consolidated results.
Year Working Capital/Sales
Mar20231.74
Mar20222.29
Mar20212.64
Mar20202.63
Mar20192.57

How is Working Capital/Sales of MEDICAMEN BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2023 1.74
-24.02
Mar2022 2.29
-13.26
Mar2021 2.64
0.38
Mar2020 2.63
2.33
Mar2019 2.57 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Working Capital/Sales ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹735.5 Cr 33.4% 51% -17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

33.4%

51%

-17%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses